Cipla House
Peninsula Business Park Ganpatrao Kadam Marg Lower Parel
Mumbai 400013
India
91 22 2482 6000
https://www.cipla.com
Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Umang Vohra B.E., M.B.A. | MD, Global CEO & Executive Director | 174.9M | N/A | 1971 |
Dr. Raju Sunil Mistry M.A., Ph.D. | President & Global Chief People Officer | N/A | N/A | 1965 |
Mr. Pradeep Bhadauria | President & Chief Scientific Officer | N/A | N/A | N/A |
Mr. Ashish Adukia | Global Chief Financial Officer | N/A | N/A | N/A |
Mr. Dinesh Ramniranjan Jain | Senior VP & Head of Corporate Finance | N/A | N/A | N/A |
Ms. Geena V. Malhotra | Global Chief Technology Officer | N/A | N/A | N/A |
Mr. Naveen Bansal | Head of Investor Relations | N/A | N/A | N/A |
Mr. Rajendra Kumar Chopra | Compliance Officer & Company Secretary | 15.3M | N/A | N/A |
Ms. Heena Kanal | Senior Vice-President of Corporate Communications | N/A | N/A | N/A |
Mr. Anurag Mishra | Head of Cipla Foundation | N/A | N/A | N/A |
Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. In addition, the company provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Further, it offers Easylax and Easylax L, a liquid paraffin for constipation. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Cipla Limited’s ISS Governance QualityScore as of June 1, 2024 is 3. The pillar scores are Audit: 4; Board: 2; Shareholder Rights: 1; Compensation: 8.